Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.NANX · Entity 7041 | Chief Financial Officer | November 16, 2017 | November 17, 2017 |
| YUNHONG GREEN CTI LTD.CTIB · Entity 8106 | Chief Financial Officer | January 12, 2018 | January 19, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date November 16, 2017 · Filed November 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 83,783 |
Ending reported balance
After 2017-11-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-11-16 · Exercise / conversion · Acquired 15,453 · Balance 99,236 Row 2 · 2017-11-16 · Sale · Disposed 15,453 · Balance 83,783 |
| Common Stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.44 · Expires 2025-02-18 | Direct | 20,547 |
Reported balance
After 2017-11-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-11-16 · Exercise / conversion · Disposed 15,453 · Balance 20,547 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.07 · Expires 2019-06-24 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2017-11-16 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 20,000 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.70 · Expires 2020-05-03 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2017-11-16 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 20,000 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.26 · Expires 2021-05-02 | Direct | 31,000 |
Reported balance
Holding disclosure · report date 2017-11-16 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 31,000 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.52 · Expires 2024-02-13 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2017-11-16 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 40,000 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2026-02-23 | Direct | 31,500 |
Reported balance
Holding disclosure · report date 2017-11-16 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 31,500 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.68 · Expires 2027-02-21 | Direct | 36,000 |
Reported balance
Holding disclosure · report date 2017-11-16 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 36,000 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
YUNHONG GREEN CTI LTD.
Report date January 12, 2018 · Filed January 19, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,000 |
Reported balance
After 2017-12-26 transaction · row 1
1 source rowRow 1 · 2017-12-26 · Purchase · Acquired 2,000 · Balance 2,000 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SIGMATRON INTERNATIONAL INC
Report date July 28, 2025 · Filed July 28, 2025
Section 16 reporting ended · disclosed 2025-07-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.93 · Expires 2034-11-11 | Direct | 0 |
Reported balance
After 2025-07-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-07-28 · Disposition to issuer · Disposed 30,000 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 20, 2025, by and among SigmaTron International, Inc. (the "Company"), Transom Axis AcquireCo, LLC ("Parent") and Transom Axis MergerSub, Inc. ("Merger Sub"). Pursuant to the Merger Agreement, Parent and MergerSub launched a tender offer (the "Offer") for all outstanding shares of common stock of the Company (the "Shares") for an offer price of $3.02 per share in cash, without interest and less any required tax withholding (the "Offer Consideration"). On July 28, 2025, Merger Sub merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the "Merger"). F2: Pursuant to the Merger Agreement, each outstanding option to purchase shares of Company common stock (a "Company Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time") and that had a per share exercise price that was less than the Offer Consideration (an "In the Money Option") was automatically accelerated and became fully vested, was cancelled and automatically converted into the right to receive for each share of Company common stock underlying such Company Option, an amount (without interest and less any required tax withholding) in cash equal to the excess of the Offer Consideration over the per share exercise price of such Company Option. At the Effective Time, each Company Option that was not an In the Money Option and that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled without any consideration payable therefor. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 20, 2025, by and among SigmaTron International, Inc. (the "Company"), Transom Axis AcquireCo, LLC ("Parent") and Transom Axis MergerSub, Inc. ("Merger Sub"). Pursuant to the Merger Agreement, Parent and MergerSub launched a tender offer (the "Offer") for all outstanding shares of common stock of the Company (the "Shares") for an offer price of $3.02 per share in cash, without interest and less any required tax withholding (the "Offer Consideration"). On July 28, 2025, Merger Sub merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the "Merger").
F2: Pursuant to the Merger Agreement, each outstanding option to purchase shares of Company common stock (a "Company Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time") and that had a per share exercise price that was less than the Offer Consideration (an "In the Money Option") was automatically accelerated and became fully vested, was cancelled and automatically converted into the right to receive for each share of Company common stock underlying such Company Option, an amount (without interest and less any required tax withholding) in cash equal to the excess of the Offer Consideration over the per share exercise price of such Company Option. At the Effective Time, each Company Option that was not an In the Money Option and that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled without any consideration payable therefor.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2025 Filed Jul 28, 2025 16:01 UTC | SIGMATRON INTERNATIONAL INC SGMA · Entity 77157 | Disposition to issuerStock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $2.93 | Not disclosed |
DisclosureSEC source: 0001140361-25-027575 · form4.xml · derivative · entry 1 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2034-11-11 F1 · kind: Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 20, 2025, by and among SigmaTron International, Inc. (the "Company"), Transom Axis AcquireCo, LLC ("Parent") and Transom Axis MergerSub, Inc. ("Merger Sub"). Pursuant to the Merger Agreement, Parent and MergerSub launched a tender offer (the "Offer") for all outstanding shares of common stock of the Company (the "Shares") for an offer price of $3.02 per share in cash, without interest and less any required tax withholding (the "Offer Consideration"). On July 28, 2025, Merger Sub merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the "Merger"). F2 · price: Pursuant to the Merger Agreement, each outstanding option to purchase shares of Company common stock (a "Company Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time") and that had a per share exercise price that was less than the Offer Consideration (an "In the Money Option") was automatically accelerated and became fully vested, was cancelled and automatically converted into the right to receive for each share of Company common stock underlying such Company Option, an amount (without interest and less any required tax withholding) in cash equal to the excess of the Offer Consideration over the per share exercise price of such Company Option. At the Effective Time, each Company Option that was not an In the Money Option and that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled without any consideration payable therefor. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each outstanding option to purchase shares of Company common stock (a "Company Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time") and that had a per share exercise price that was less than the Offer Consideration (an "In the Money Option") was automatically accelerated and became fully vested, was cancelled and automatically converted into the right to receive for each share of Company common stock underlying such Company Option, an amount (without interest and less any required tax withholding) in cash equal to the excess of the Offer Consideration over the per share exercise price of such Company Option. At the Effective Time, each Company Option that was not an In the Money Option and that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled without any consideration payable therefor. Read SEC document |
| November 11, 2024 Filed Nov 15, 2024 16:29 UTC | SIGMATRON INTERNATIONAL INC SGMA · Entity 77157 | GrantStock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $2.93 | Not disclosed |
DisclosureSEC source: 0000950170-24-127612 · ownership.xml · derivative · entry 4 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 7,500 shares Expires 2034-11-11 F1 · security: The 7,500 options acquired as described on this Table II were issued on November 11, 2024 pursuant to and under a single stock option plan and stock option agreement. F2 · price: This column needs to be blank. Read SEC document |
| November 11, 2024 Filed Nov 15, 2024 16:29 UTC | SIGMATRON INTERNATIONAL INC SGMA · Entity 77157 | GrantStock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $2.93 | Not disclosed |
DisclosureSEC source: 0000950170-24-127612 · ownership.xml · derivative · entry 3 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 7,500 shares Expires 2034-11-11 F1 · security: The 7,500 options acquired as described on this Table II were issued on November 11, 2024 pursuant to and under a single stock option plan and stock option agreement. F2 · price: This column needs to be blank. Read SEC document |
| November 11, 2024 Filed Nov 15, 2024 16:29 UTC | SIGMATRON INTERNATIONAL INC SGMA · Entity 77157 | GrantStock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $2.93 | Not disclosed |
DisclosureSEC source: 0000950170-24-127612 · ownership.xml · derivative · entry 2 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 7,500 shares Expires 2034-11-11 F1 · security: The 7,500 options acquired as described on this Table II were issued on November 11, 2024 pursuant to and under a single stock option plan and stock option agreement. F2 · price: This column needs to be blank. Read SEC document |
| November 11, 2024 Filed Nov 15, 2024 16:29 UTC | SIGMATRON INTERNATIONAL INC SGMA · Entity 77157 | GrantStock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $2.93 | Not disclosed |
DisclosureSEC source: 0000950170-24-127612 · ownership.xml · derivative · entry 1 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-11-11 F1 · security: The 7,500 options acquired as described on this Table II were issued on November 11, 2024 pursuant to and under a single stock option plan and stock option agreement. F2 · price: This column needs to be blank. Read SEC document |
| December 26, 2017 Filed Jan 19, 2018 18:04 UTC | YUNHONG GREEN CTI LTD. CTIB · Entity 8106 | PurchaseCommon Stock | 2,000 | $4.20 | $8,400.00 |
DisclosureSEC source: 0001437749-18-000816 · rdgdoc.xml · nonDerivative · entry 1 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 19:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to buy) · Derivative | 15,453 | $0.44 Strike: $0.44 | $6,799.32 |
DisclosureSEC source: 0001209191-17-061418 · doc4.xml · derivative · entry 7 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,547 Underlying: Common Stock · 15,453 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 19:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 15,453 | $0.58 | $8,962.74 |
DisclosureSEC source: 0001209191-17-061418 · doc4.xml · nonDerivative · entry 2 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,783 Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 19:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 15,453 | $0.44 | $6,799.32 |
DisclosureSEC source: 0001209191-17-061418 · doc4.xml · nonDerivative · entry 1 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 14:04 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to buy) · Derivative | 13,000 | $0.42 Strike: $0.42 | $5,395.00 |
DisclosureSEC source: 0001209191-17-061053 · doc4.xml · derivative · entry 11 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,000 shares Expires 2023-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 14:04 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to buy) · Derivative | 13,667 | $0.30 Strike: $0.30 | $4,100.10 |
DisclosureSEC source: 0001209191-17-061053 · doc4.xml · derivative · entry 10 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,667 shares Expires 2022-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 14:04 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 13,000 | $0.59 | $7,670.00 |
DisclosureSEC source: 0001209191-17-061053 · doc4.xml · nonDerivative · entry 6 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,783 Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 14:04 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 13,000 | $0.42 | $5,460.00 |
DisclosureSEC source: 0001209191-17-061053 · doc4.xml · nonDerivative · entry 5 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 14:04 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 6,167 | $0.61 | $3,761.87 |
DisclosureSEC source: 0001209191-17-061053 · doc4.xml · nonDerivative · entry 4 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,783 Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 14:04 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 6,167 | $0.30 | $1,850.10 |
DisclosureSEC source: 0001209191-17-061053 · doc4.xml · nonDerivative · entry 3 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 14:04 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 7,400 | $0.61 | $4,514.00 |
DisclosureSEC source: 0001209191-17-061053 · doc4.xml · nonDerivative · entry 2 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,783 Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 14:04 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 7,400 | $0.30 | $2,220.00 |
DisclosureSEC source: 0001209191-17-061053 · doc4.xml · nonDerivative · entry 1 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 21:21 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 36,000 | $0.68 Strike: $0.68 | $24,480.00 |
DisclosureSEC source: 0001209191-17-013225 · doc4.xml · derivative · entry 10 CESARIO FRANK · CIK 0001267497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.